Journal
ORGANIC & BIOMOLECULAR CHEMISTRY
Volume 13, Issue 6, Pages 1768-1777Publisher
ROYAL SOC CHEMISTRY
DOI: 10.1039/c4ob02376e
Keywords
-
Categories
Funding
- AstraZeneca
- Pfizer
- Reaxa
- Technology Strategy Board [TP14/HVM/6/I-BD368B]
- Royal Society
Ask authors/readers for more resources
An immobilised iridium hydrogen transfer catalyst has been developed for use in flow based processing by incorporation of a ligand into a porous polymeric monolithic flow reactor. The monolithic construct has been used for several redox reductions demonstrating excellent recyclability, good turnover numbers and high chemical stability giving negligible metal leaching over extended periods of use.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available